Semaglutide 15mg Vials Lyophilized Raw Powder
Semaglutide 15mg Vials Lyophilized Raw Powder

Semaglutide 15mg Vials Lyophilized Raw Powder

Semaglutide is a synthetic GLP-1 receptor agonist peptide supplied in this product as 15 mg lyophilized raw powder per vial. Its molecular activity involves GLP-1 receptor pathways associated with glucose regulation and appetite control.
Send Inquiry

Product Overview

 

Semaglutide is a synthetic GLP-1 receptor agonist peptide supplied in this product as 15 mg lyophilized raw powder per vial. Its molecular activity involves GLP-1 receptor pathways associated with glucose regulation and appetite control.

 

Technical Specifications

 

Parameter

Specification

Product Name

Semaglutide

Listed Strength

15 mg

Product Form

Lyophilized Raw Powder

Packaging Format

Vial

Product Category

GLP-1 Receptor Agonist

 

Mechanism of Action

 

GLP-1 Receptor Activation: Semaglutide acts on glucagon-like peptide-1 (GLP-1) receptors, mimicking the activity of the natural GLP-1 hormone involved in blood glucose regulation and appetite control.

 

Glucose-Dependent Insulin Secretion: It stimulates insulin secretion in response to elevated blood glucose, helping regulate blood sugar levels.

 

Glucagon Regulation: Semaglutide reduces glucagon secretion when blood glucose is elevated, helping limit excess glucose release by the liver.

 

Delayed Gastric Emptying: It slows gastric emptying, which can influence post-meal blood glucose levels and prolong feelings of fullness.

 

Appetite and Satiety Regulation: Its action on GLP-1 receptors involved in appetite regulation can reduce hunger and energy intake, contributing to weight loss in approved treatment settings.

 

Analytical Testing

 

Identity Testing: Mass spectrometry (MS) characterizes molecular mass and supports confirmation of semaglutide identity.

 

Purity Testing: Reversed-phase high-performance liquid chromatography (RP-HPLC) separates the main peptide component from chromatographically detectable impurities.

 

Water Content: Karl Fischer titration measures water content in the lyophilized material.

 

Residual Solvents: Gas chromatography (GC) measures residual organic solvents against applicable analytical specifications.

 

Quality Documentation

 

Certificate of Analysis (CoA): Batch-specific analytical report containing test results, test methods, and applicable acceptance criteria.

 

Product Specification: Technical document defining product identity, stated strength, physical form, and applicable quality limits.

 

Safety Data Sheet (SDS): Safety information covering material hazards, handling precautions, storage, and transport considerations.

 

Packaging & Product Identification

 

Vial Presentation: 15 mg lyophilized semaglutide raw powder per vial.

 

Batch Identification: Batch number and manufacturing or expiry information identify the relevant production lot.

 

Retail or Bulk Packaging: 10 vials per box, with outer packaging identified according to the order configuration.
 

Storage & Transportation

 

Storage Conditions: Store sealed lyophilized powder at −20°C, protected from light and moisture, for long-term storage.

 

Transportation: Use protective, moisture-resistant packaging and temperature-controlled shipping when required by the specified transport conditions.

 

Shelf Life: 24 months from the manufacturing date when stored under the specified conditions.

 

Supply & Commercial Terms

 

Minimum Order Quantity (MOQ): 1 box, containing 10 vials of Semaglutide 15 mg.

 

Sample Orders: 1 vial available for initial product evaluation.

 

Lead Time: 7–14 business days after order and payment confirmation.

 

Shipping: International shipping available, with freight charges and transit times based on destination and shipping method.

 

Payment Terms: Bank transfer (T/T), according to the payment schedule stated in the proforma invoice.

 

Bulk Orders: Volume-based pricing available for larger quantities.

 

After-Sales Service

 

Product Quality Complaints: Investigate reported quality issues using batch details, photographs, and available analytical records.

 

Incorrect or Missing Items: Review discrepancies in product type, vial quantity, labeling, and delivered order contents.

 

Shipping Damage: Assist with documenting damaged packaging, shipment delays, and delivery discrepancies for resolution with the relevant shipping party.

 

Issue Resolution: Communicate investigation findings and agreed corrective actions to the customer.

 

Product Description

1
2
3
4
4e1ca48d850dacc17be09ad63bf95b48
6

 

Our Factory

 

product-800-1125

product-800-431

 

Delivery And Transportation

 

jpg

product-800-392

 

FAQ

 

Q: What is the CAS number and molecular formula of semaglutide?

A: Semaglutide has CAS number 910463-68-2 and molecular formula C₁₈₇H₂₉₁N₄₅O₅₉. Its molecular weight is approximately 4,114 g/mol

Q: Is semaglutide sodium the same as semaglutide?

A: No. Semaglutide sodium and semaglutide acetate are salt forms that differ from the active ingredient used in approved semaglutide medicines. They should not be treated as interchangeable.

Q: Is Semaglutide 15mg lyophilized powder a finished injectable medicine?

A: No. Lyophilized raw powder is a raw material presentation, not a finished sterile injectable drug product. A vial strength alone does not establish sterility, formulation suitability, or authorization for human administration.

Q: What is the difference between semaglutide and tirzepatide?

A: Semaglutide activates GLP-1 receptors, whereas tirzepatide activates both GIP and GLP-1 receptors. They are distinct peptide active ingredients with different molecular structures and should not be substituted on a milligram-for-milligram basis.

Q: Does 15 mg per vial mean 15 mg/mL?

A: No. 15 mg per vial describes the total stated amount in the vial, while mg/mL describes concentration. Concentration depends on the final solution volume and cannot be inferred from vial strength alone.

Q: What factors determine the quality of semaglutide raw material?

A: Key quality attributes include confirmed molecular identity, peptide purity, related impurities, water content, and compliance with the applicable material specification. For pharmaceutical manufacturing, additional requirements depend on the intended formulation and applicable quality standards.

Q: Can semaglutide raw powder be imported for pharmaceutical manufacturing in any country?

A: No. Importation and use are subject to the destination country's pharmaceutical, customs, and active pharmaceutical ingredient regulations. In the United States, FDA restrictions apply to compounding with bulk semaglutide, and purchasing raw material does not itself authorize its use in compounded medicines.

Hot Tags: semaglutide 15mg vials lyophilized raw powder, China semaglutide 15mg vials lyophilized raw powder suppliers, factory, 99 Purity tirzepatide, MT2, MT2 Melanotan II 10mg Peptide, Tirzepatide 20mg 10 Vials Powder Weight Loss, tirzepatide 40mg, Tirzepatide 40mg Vial Dosage Peptide

Looking for High-qualityWeight Loss Peptides?

With reliable stock, fast bulk delivery, custom packaging and OEM/ODM services,
we aim to be your trusted partner for peptide raw materials.

Send Inquiry